Study Enrollment

Your details will not be published or shared.

Clinical Trial

(ASPIRE) Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery

This study is for people who have A-Fib (atrial fibrillation) and recently had a stroke. This study is to see if Eliquis or aspirin is better in preventing strokes and death.

Eligibility Criteria

  • Adults who have had an intracranial hemorrhage (ICH) confimed by CT or MRI within 14-120 days of being screened to participate.

Contact Information

    Fenwick Nichols, MD

    706 721-1691